The 2023 Pharma Proposals on Proxy

Company: AbbVie. Proposal Patents and Access. Proponent: Friends Fiduciary. Read the exempt solicitation here

Company: Eli Lilly. Proposal Patents and Access. Proponent:  Trinity Health. Read the exempt solicitation hereLobbying Alignment. Proponent: CommonSpirit Health. Read the exempt solicitation here.

Company: Gilead. Proposal: Patents and Access. Proponent: Adrian Dominican Sisters. Read the exempt solicitation here.

Company: Johnson & Johnson. Proposal: Patents and AccessRead the exempt solicitation here. Proponent: Mercy Investment Services. Proposal: COVID-19 Products. Proponent: Oxfam. Read the exempt solicitation here.

Company: Merck. Proposal: Patents and Access. Proponent: Province of St. Joseph of the Capuchin Order. Read the exempt solicitation here. Proposal: Public Investment in COVID-19 Products. Proponent: Oxfam. Read the exempt solicitation here.

Company: Moderna. Proposal: COVID-19 Tech Transfer. Proponent: Oxfam. Read the exempt solicitation here.

Company: Pfizer. Proposal: Patents and AccessRead the exempt solicitation here. Proponent: Trinity Health. Tech Transfer. Proponent: Oxfam. Read the exempt solicitation here.

Company: Regeneron. Proposal Patents and Access. Proponent: Boston Common Asset Management.  

Sign Up for our eNewsletter

* indicates required